8-K filed today includes Tuesday’s 5/19/20 PR and today’s shareholder alert. Leo is dotting the i’s and crossing the t’s as the science continues to advance. Today’s alert highlights the uniqueness of Brilacidin essentially killing COVID-19 upon contact vs other known antivirals only preventing replication once host cells have already been infected. Brilacidin has the potential to both disrupt the virus directly AND prevent viral entry into host cells. The term “GOLD STANDARD” has a nice ring to it!